n-vinyl-2-pyrrolidinone has been researched along with Hypertriglyceridemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Araki, E; Ishibashi, S; Matsuba, I; Matsuba, R; Suganami, H; Yamashita, S; Yokote, K | 1 |
1 trial(s) available for n-vinyl-2-pyrrolidinone and Hypertriglyceridemia
| Article | Year |
|---|---|
Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.
Topics: Adult; Blood Glucose; Female; Glucose; Glucose Clamp Technique; Humans; Hypertriglyceridemia; Insulin Resistance; Liver; Liver Circulation; Male; Methylmethacrylates; Middle Aged; Povidone; PPAR alpha; Treatment Outcome | 2018 |